JP2014169285A5 - - Google Patents

Download PDF

Info

Publication number
JP2014169285A5
JP2014169285A5 JP2014019893A JP2014019893A JP2014169285A5 JP 2014169285 A5 JP2014169285 A5 JP 2014169285A5 JP 2014019893 A JP2014019893 A JP 2014019893A JP 2014019893 A JP2014019893 A JP 2014019893A JP 2014169285 A5 JP2014169285 A5 JP 2014169285A5
Authority
JP
Japan
Prior art keywords
production example
dimethyl
iodophenyl
trifluoromethyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014019893A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014169285A (ja
JP5799117B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014019893A priority Critical patent/JP5799117B2/ja
Priority claimed from JP2014019893A external-priority patent/JP5799117B2/ja
Publication of JP2014169285A publication Critical patent/JP2014169285A/ja
Publication of JP2014169285A5 publication Critical patent/JP2014169285A5/ja
Application granted granted Critical
Publication of JP5799117B2 publication Critical patent/JP5799117B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014019893A 2013-02-05 2014-02-05 ウラシル誘導体からなる医薬 Expired - Fee Related JP5799117B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014019893A JP5799117B2 (ja) 2013-02-05 2014-02-05 ウラシル誘導体からなる医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013020426 2013-02-05
JP2013020426 2013-02-05
JP2014019893A JP5799117B2 (ja) 2013-02-05 2014-02-05 ウラシル誘導体からなる医薬

Publications (3)

Publication Number Publication Date
JP2014169285A JP2014169285A (ja) 2014-09-18
JP2014169285A5 true JP2014169285A5 (https=) 2015-04-30
JP5799117B2 JP5799117B2 (ja) 2015-10-21

Family

ID=51691962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014019893A Expired - Fee Related JP5799117B2 (ja) 2013-02-05 2014-02-05 ウラシル誘導体からなる医薬

Country Status (1)

Country Link
JP (1) JP5799117B2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017207430A1 (en) * 2016-05-31 2017-12-07 Chiesi Farmaceutici S.P.A. Imidazolone compounds as human neutrophil elastase inhibitors
AU2017279027A1 (en) * 2016-06-08 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Chemical Compounds
US12522587B2 (en) 2018-05-04 2026-01-13 Remedy Plan, Inc. Cancer treatments targeting cancer stem cells
EP4055008A1 (en) 2019-11-06 2022-09-14 Remedy Plan, Inc. Cancer treatments targeting cancer stem cells
GB201918414D0 (en) * 2019-12-13 2020-01-29 Z Factor Ltd Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency
EP3945091B1 (en) * 2020-07-31 2024-01-03 Abarceo AB Novel vdac1 inhibitors
WO2023033097A1 (ja) * 2021-09-02 2023-03-09 Ｅａファーマ株式会社 複素環スルホンアミド誘導体の製造方法、およびその合成中間体
CN113952359A (zh) * 2021-11-19 2022-01-21 大连理工大学盘锦产业技术研究院 顺铂与Tri-1的联合抗肺癌药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200500341A (en) * 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
CN104024241B (zh) * 2011-08-01 2016-01-20 大日本住友制药株式会社 尿嘧啶衍生物和其用于医学目的的用途

Similar Documents

Publication Publication Date Title
JP2014169285A5 (https=)
US11186582B2 (en) Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitors
DE602004010206T2 (de) Dipeptidyl Peptidase Inhibitoren.
AU2020407200A1 (en) Irak degraders and uses thereof
US8084466B2 (en) Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor
CY1111651T1 (el) Παραγωγα 3-(ετεροαρυλ-oξυ)-2-αλκυλ-1-αζα- δικυκλοαλκυλιου ως συνδετες του αλφα.7-nachr για τη θεραπεια των ασθενειων του κνς
JP2022536092A5 (https=)
US9518055B2 (en) Imidazopyridyl compounds as aldosterone synthase inhibitors
WO2015059618A1 (en) SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS
WO2006064355A3 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
JP2008502628A5 (https=)
TW201041830A (en) Preparation method for bicyclic gamma-amino acid derivative
CN103328468A (zh) 用于治疗疼痛、精神障碍、认知损害或阿尔茨海默病的α-7烟碱型受体调节剂
JP2011525528A (ja) タンパク質キナーゼ阻害剤
WO2008109856A3 (en) Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions
JP2016500121A (ja) イミダゾピリジン誘導体
US10202401B2 (en) Process for making tetracyclic heterocycle compounds
US10131674B2 (en) Process for preparing Substituted Indole Compounds
CN105272921A (zh) 一种制备Ceritinib的方法及其中间体化合物
CN112409193B (zh) 高纯度(-)-肾上腺素及其制备方法
WO2026090477A1 (en) Helicase inhibitors and uses thereof
CN103396367B (zh) 含扁桃酸基团的吡唑双酰胺类化合物及制备方法和用途
CN112312969A (zh) 2,3-二氢呋喃并[2,3-b]吡啶化合物
HK1228895B (en) Substituted [1,2,4]triazolo [1,5-a]pyrimidin-7-yl compounds as pde2 inhibitors
HK1228895A1 (en) Substituted [1,2,4]triazolo [1,5-a]pyrimidin-7-yl compounds as pde2 inhibitors